S
APGE

SignatureFD’s Apogee Therapeutics APGE Stock Holding History

SignatureFD’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.98K Buy
30
+17
+131% +$1.53K ﹤0.01% 2932
2026
Q1 		$1.09K Hold
13
– – ﹤0.01% 3191
2025
Q4 		$981 Hold
13
– – ﹤0.01% 3122
2025
Q3 		$516 Sell
13
-15
-54% -$573 ﹤0.01% 3188
2025
Q2 		$1.22K Buy
28
+3
+12% +$114 ﹤0.01% 2978
2025
Q1 		$934 Buy
+25
New +$967 ﹤0.01% 3049

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

SignatureFD's APGE Position: Q2 2026 in Review

SignatureFD increased its Apogee Therapeutics (APGE) stake by 131% in Q2 2026, buying an estimated $1.53K and bringing the position to 30 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

SignatureFD first reported a position in APGE in Q1 2025 and has held it in 6 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • SignatureFD held 30 shares of Apogee Therapeutics worth $3.98K as of Q2 2026.
  • SignatureFD bought 17 Apogee Therapeutics shares in Q2 2026, an estimated $1.53K.
  • Apogee Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2932 holding.
  • SignatureFD first reported a position in Apogee Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.